Zilebesiran, an RNA interference therapeutic agent, shows promise for controlling high blood pressure with biannual injections. This novel treatment approach may offer improved blood pressure management for individuals with hypertension.
March 2024
The latest evidence-based treatments for heart failure are incorporated into state-of-the-art management recommendations in the newly published European heart failure guide, providing clinicians with updated guidelines for optimizing patient care.
March 2024